IQV
IQVIA Holdings Inc
NYSE: IQV · HEALTHCARE · DIAGNOSTICS & RESEARCH
$156.66
-1.46% today
Updated 2026-04-29
Market cap
$26.30B
P/E ratio
20.01
P/S ratio
1.61x
EPS (TTM)
$7.83
Dividend yield
—
52W range
$135 – $247
Volume
1.8M
IQVIA Holdings Inc (IQV) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $378.16M | $160.95M | $335.70M | $397.37M | $431.75M | $475.69M | $860.00M | $970.00M | $1.25B | $1.42B | $1.96B | $2.94B | $2.26B | $2.15B | $2.72B | $2.65B |
| Capital expenditures | $80.24M | $75.68M | $71.34M | $92.35M | $82.65M | $78.39M | $164.00M | $369.00M | $459.00M | $582.00M | $616.00M | $640.00M | $674.00M | $649.00M | $602.00M | $603.00M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $17.33M | $14.13M | $25.93M | $22.83M | $30.00M | $37.76M | $80.00M | $106.00M | $113.00M | $146.00M | $95.00M | $170.00M | $194.00M | $217.00M | $206.00M | $247.00M |
| Free cash flow | $297.92M | $85.27M | $264.37M | $305.02M | $349.10M | $397.30M | $696.00M | $601.00M | $795.00M | $835.00M | $1.34B | $2.30B | $1.59B | $1.50B | $2.11B | $2.05B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $67.49M | $288.32M | $567.85M | $2.07B | $425.00M | $2.25B | $638.00M | $7.16B | $4.08B | $11.00M | $44.00M | $59.00M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $210.41M | $89.22M | $109.79M | $221.00M | $-239.00M | $-68.00M | $-49.00M | $946.00M | $-396.00M | $-75.00M | — | — | — |